Document Detail


Effects of a typical and an atypical antipsychotic on the disruption of prepulse inhibition caused by corticotropin-releasing factor and by rat strain.
MedLine Citation:
PMID:  16187833     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Male Wistar-Kyoto (WKY) and Brown Norway (BN) rats (11-12 weeks, n = 184) received an injection of saline, haloperidol, or clozapine, followed by an intracerebroventricular infusion of saline or corticotropin-releasing factor (CRF). Rats were tested for prepulse inhibition (PPI) of the acoustic startle response. BN rats showed less PPI than WKY rats, and neither antipsychotic alone enhanced PPI. In WKY rats, both haloperidol and clozapine attenuated the CRF-induced decrease in PPI. In CRF-treated BN rats, clozapine-enhanced PPI. A clozapine-induced decrease in startle amplitude was seen in CRF-treated BN rats but not in CRF-treated WKY rats. Although the disruption of PPI caused by exogenous CRF administration can be reversed by acute antipsychotic treatment, baseline PPI is not altered.
Authors:
Lisa H Conti; Jennifer E Costill; Sean Flynn; Jane E Tayler
Related Documents :
18824493 - Genetic analysis of salt-sensitive hypertension in dahl rats reveals a link between car...
15464193 - Genotype-dependent effect of acth1-24 on grooming and yawning in two inbred strains of ...
11575683 - Importance of storage conditions for the stability of zinc- and cadmium-induced metallo...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  Behavioral neuroscience     Volume:  119     ISSN:  0735-7044     ISO Abbreviation:  Behav. Neurosci.     Publication Date:  2005 Aug 
Date Detail:
Created Date:  2005-09-28     Completed Date:  2006-01-23     Revised Date:  2007-11-14    
Medline Journal Info:
Nlm Unique ID:  8302411     Medline TA:  Behav Neurosci     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1052-60     Citation Subset:  IM    
Copyright Information:
(c) 2005 APA
Affiliation:
Department of Psychiatry, University of Connecticut Health Center, Farmington, CT 06030, USA. conti@psychiatry.uchc.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Acoustic Stimulation / methods
Analysis of Variance
Animals
Antipsychotic Agents / pharmacology*
Behavior, Animal / drug effects
Clozapine / pharmacology
Corticotropin-Releasing Hormone / pharmacology*
Dose-Response Relationship, Drug
Dose-Response Relationship, Radiation
Drug Interactions
Haloperidol / pharmacology
Hormones / pharmacology*
Injections, Intraventricular / methods
Male
Neural Inhibition / drug effects*
Rats
Rats, Inbred BN
Rats, Inbred WKY
Startle Reaction / drug effects*
Grant Support
ID/Acronym/Agency:
MH65467/MH/NIMH NIH HHS
Chemical
Reg. No./Substance:
0/Antipsychotic Agents; 0/Hormones; 52-86-8/Haloperidol; 5786-21-0/Clozapine; 9015-71-8/Corticotropin-Releasing Hormone

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Corticotropin-releasing factor type II (CRF-sub-2) receptors in the bed nucleus of the stria termina...
Next Document:  Urocortin 1 and 3 impair maternal defense behavior in mice.